Structured evidence table for Sage Cognitive Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sage Cognitive Performance Randomized Trial | This gap underscores the rationale for systematically reviewing the available evidence, not only to consolidate findings but also to highlight the scope and limitations of current approaches in managing cognitive decline in AD. | 1 | Krishna Dwivedi (2026) | Mind–Body Interventions as Modulators of Neural Connectivity and Cognition in Individuals at Risk for Alzheimer’s Disease: A Systematic Review |
| Sage Cognitive Performance Randomized Trial | Herein lies the importance of systematic reviews by synthesising disparate lines of evidence; such reviews can critically evaluate the efficacy and safety of these complementary interventions, identify gaps in the current literature and guide future clinical applications. | 1 | Krishna Dwivedi (2026) | Mind–Body Interventions as Modulators of Neural Connectivity and Cognition in Individuals at Risk for Alzheimer’s Disease: A Systematic Review |
| Sage Cognitive Performance Randomized Trial | The present systematic review is, therefore, undertaken with the aim of addressing this critical need, consolidating the existing evidence on yoga interventions in AD, and providing a framework for future research and clinical integration. | 1 | Krishna Dwivedi (2026) | Mind–Body Interventions as Modulators of Neural Connectivity and Cognition in Individuals at Risk for Alzheimer’s Disease: A Systematic Review |
| Sage Cognitive Performance Randomized Trial | The condition is characterised by insidious onset and progressive decline in multiple domains of cognition, including memory, language, executive functioning and visuospatial abilities, ultimately impairing functional independence and quality of life. | 1 | Krishna Dwivedi (2026) | Mind–Body Interventions as Modulators of Neural Connectivity and Cognition in Individuals at Risk for Alzheimer’s Disease: A Systematic Review |
| Sage Cognitive Performance Randomized Trial | Physiological, psychosocial, and neuroendocrine changes associated with aging lead to substantial alterations in sleep architecture. | 2 | Ede Sarıkaya Belçim (2026) | Effects of inhaled aromatherapy on sleep quality and cognitive function in older adults: a randomised controlled trial |
| Sage Cognitive Performance Randomized Trial | , , Pharmacological interventions for sleep problems in older adults are associated with important risks, including falls, cognitive impairment, and dependency.Consequently, safer and more sustainable non-pharmacological approaches have gained increasing attention. | 2 | Ede Sarıkaya Belçim (2026) | Effects of inhaled aromatherapy on sleep quality and cognitive function in older adults: a randomised controlled trial |
| Sage Cognitive Performance Randomized Trial | H: There is a statistically significant difference between the intervention and control groups, such that older adults receiving inhalation aromatherapy demonstrate improved objective and subjective sleep outcomes and better cognitive performance (orientation, memory, and concentration) compared with the control group. | 2 | Ede Sarıkaya Belçim (2026) | Effects of inhaled aromatherapy on sleep quality and cognitive function in older adults: a randomised controlled trial |
| Sage Cognitive Performance Randomized Trial | Global demographic trends indicate a substantial increase in the aging population, leading to profound transformations in health, economic, and social systems worldwide. | 2 | Ede Sarıkaya Belçim (2026) | Effects of inhaled aromatherapy on sleep quality and cognitive function in older adults: a randomised controlled trial |
Source documents